Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults
Clinical trial NCT07183709 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07183709
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-02
- Primary completion
- 2026-10-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.